healthday26m
FDA Approves First Flu Vaccine You Give Yourself at Home
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Admi ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
Recall alert: Dynacare Baby Powder recalled due to potential asbestos contamination
The Food and Drug Administration announced the recall of 62 cases of baby powder that could be contaminated with asbestos.
Dozens of Boar’s Head workers scrubbing plant infected by listeria — as company has no plans to reopen it
In an email to The Post this week, a Boar’s Head spokesperson said, “We do not currently have any plans to reopen this plant.
FDA Approves Zevra's Miplyffa for Niemann-Pick Disease Type C -- 2nd Update
Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...
STAT1h
FDA’s new head of device safety held senior role at company troubled by safety warnings
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...
Health.com1h
Multiple Reports Have Found Lead in Cinnamon—Is It Still Safe to Eat?
Recent testing from Consumer Reports and the FDA has found elevated levels of lead in cinnamon products and spice mixes. You ...
FDA Approves First Treatment for Niemann-Pick Disease, Type C
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).